Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients.
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Biomarker; Pharmacodynamics
- 24 Apr 2017 Status changed from active, no longer recruiting to completed.
- 03 Dec 2011 New trial record